Diverse H. pylori strains,IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province,China

In Hexi area of Gansu Province, people have a higher susceptibility of gastric cancer than people in the rest area of China. There is substantial geographic variation in the incidence of gastric cancer. In this article, the present author explored the roles of H. pylori infection and IL-10 promoter polymorphisms in development of gastric cancer in this area. A total of 304 participants were admitted to our study, and they were divided into two groups: control group and case group. Blood samples from all subjects were collected for gene extraction using DNA extraction kits. IL-10 polymorphisms were determined by SNaPshot Multiplex. To test H. pylori infection and its typing H. pylori antibody Immunoblotting Kits were used. This research suggested that environmental factor played an important role in the pathogenesis of gastric carcinoma in the area, H. pylori infection increased the risk of gastric cancer (OR = 2.612, 95% CI 1.636-4.170) and subject with H. pylori I-type positive was at significantly higher risk for progression to gastric cancer (OR = 4.712, 95% CI 2.656-8.537). For subjects with the ATA/GCC or GCC/GCC haplotype of the IL-10-1082/-819/-592 polymorphism relative to the ATA/ATA haplotype group, the risk of gastric cancer development was significantly increased. It has been demonstrated that the presence of IL-10-819 C alleles and IL-10-592 C alleles was associated with an increased risk for gastric cancer development in H. pylori-infected patients and IL-10 promoter polymorphisms and H. pylori have a synergistic effect on gastric cancer in Hexi population.     

Preparation and up‐conversion luminescence properties of LaOBr:Yb3+/Er3+ nanofibers via electrospinning

LaOBr:Yb³⁺/Er³⁺ nanofibers were synthesized for the first time by calcinating electrospun PVP/[La(NO₃)₃ + Er(NO₃)₃ + Yb(NO₃)₃ + NH₄Br] composites. The morphology and properties of the final products were investigated in detail using scanning electron microscopy (SEM), energy dispersion spectroscopy (EDS), X‐ray diffractometry (XRD) and fluorescence spectroscopy. The results indicate that LaOBr:Yb³⁺/Er³⁺ nanofibers are tetragonal in structure with a space group of P4/nmm. The diameter of LaOBr:Yb³⁺/Er³⁺ nanofibers is ~ 147 nm. Under the excitation of a 980‐nm diode laser, LaOBr:Yb³⁺/Er³⁺ nanofibers emit strong green and red up‐conversion emission centering at 519, 541 and 667 nm, ascribed to the ²H_11/2, ⁴S_3/2 → ⁴I_15/2 and ⁴ F_9/2 → ⁴I_15/2 energy‐level transitions of Er³⁺ ions, respectively. The up‐conversion luminescent mechanism of LaOBr:Yb³⁺/Er³⁺ nanofibers is advanced. Moreover, near‐infrared emission of LaOBr:Yb³⁺/Er³⁺ nanofibers is obtained under the excitation of a 532‐nm laser. The formation mechanism of LaOBr:Yb³⁺/Er³⁺ nanofibers is proposed. LaOBr:Yb³⁺/Er³⁺ nanofibers could be important up‐conversion luminescent materials. Copyright © 2014 John Wiley & Sons, Ltd.     

高山雪鸡繁殖生态研究

本文报道了高山雪鸡(Tetraogallus himalayensis)的繁殖生态,主要内容包括栖息地,活动规律,雌雄比例,求偶行为,巢和卵,孵化,雏鸟,食物和天敌。     

Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway

Tamoxifen is a widely used personalized medicine for estrogen receptor (ER)-positive breast cancer, but approximately 30% of patients receiving the treatment relapse due to tamoxifen resistance (TamR). Recently, several reports have linked lncRNAs to cancer drug resistance. However, the role of lncRNAs in TamR is unclear. To identify TamR-related lncRNAs, we first used a bioinformatic approach to predict whether they have connection with known TamR-associated genes by starBase v2.0 and divided them into two groups. Group A contains lncRNAs that connect with known TamR genes and group B contains lncRNAs that show no predicted interaction. Among the 12 lncRNAs in group A, 58.3% of them are either up- or downregulated in MCF-7/TamR cells compared to the sensitive cells. In contrast, the expression levels of all group B lncRNAs are not changed in MCF-7/TamR cells. LINC00894-002 exhibits the most sophisticated network pattern and is the most downregulated lncRNA in MCF-7/TamR cells. Moreover, we find that LINC00894-002 is directly upregulated by ERα. Knocking down LINC00894-002 downregulates expression of miR-200a-3p and miR-200b-3p, upregulates the expression of TGF-β2 and ZEB1, and finally contributes to TamR. Herein, we report the first case of an inhibitory lncRNA against TamR through the miR-200-TGF-β2-ZEB1 signaling pathway.     

AKR1B10 protects against UVC-induced DNA damage in breast cancer cells

The cellular response to DNA damage is crucial for maintaining the integrity and stability of molecular structure.To maintain genome stability,DNA-damaged cells...     

Electrospinning preparation and photoluminescence properties of Y3Al5O12:Tb3+ nanostructures

Novel nanostructures of Y₃Al₅O₁₂:Tb³⁺ (denoted as YAG:Tb³⁺ for short) nanobelts and nanofibers were fabricated by calcination of the respective electrospun PVP/[Y(NO₃)₃ + Tb(NO₃)₃ + Al(NO₃)₃] composite nanobelts and nanofibers. YAG:Tb³⁺ nanostructures are cubic in structure with a space group of I_a3d. The thickness and width of the YAG:7%Tb³⁺ nanobelts are respectively ca. 125 nm and 5.9 ± 0.3 µm, and the diameter of YAG:7%Tb³⁺ nanofibers is 166.0 ± 20 nm (95% confidence level). The YAG:Tb³⁺ nanostructures emit predominantly at 544 nm from the energy levels transition of ⁵D₄ → ⁷ F₅ of Tb³⁺ ions under the excitation of 274‐nm ultraviolet light. It was found that the optimum doping molar concentration of Tb³⁺ ions for YAG:Tb³⁺ nanostructures was 7%. Compared with YAG:7%Tb³⁺ nanofibers, YAG:7%Tb³⁺ nanobelts exhibit a stronger photoluminescence (PL) intensity under the same doping concentration. Commission International de l'Eclairage (CIE) analysis demonstrates that the emitting colors of YAG:Tb³⁺ nanostructures are located in the green region and color‐tuned luminescence can be obtained by changing the doping concentration of Tb³⁺ and morphologies of the nanostructures, which could be applied in the field of optical telecommunication and optoelectronic devices. The possible formation mechanisms of YAG:Tb³⁺ nanobelts and nanofibers are also proposed. Copyright © 2014 John Wiley & Sons, Ltd.     

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease

Non‐alcoholic fatty liver disease (NAFLD) can progress to the more serious non‐alcoholic steatohepatitis (NASH), characterized by inflammatory injury and fibrosis. The pathogenic basis of NAFLD progressing to NASH is currently unknown, but growing evidence suggests MD2 (myeloid differentiation factor 2), an accessory protein of TLR4, is an important signalling component contributing to this disease. We evaluated the effectiveness of the specific MD2 inhibitor, L6H21, in reducing inflammatory liver injury in a relevant high‐fat diet (HFD) mouse model of NASH and in the palmitic acid (PA)‐stimulated human liver cell line (HepG2). For study, genetic knockout (MD2^?/?) mice were fed a HFD or control diet for 24 weeks, or wild‐type mice placed on a similar diet regimen and treated with L6H21 for the last 8 or 16 weeks. Results indicated that MD2 inhibition with L6H21 was as effective as MD2 knockout in preventing the HFD‐induced hepatic lipid accumulation, pro‐fibrotic changes and expression of pro‐inflammatory molecules. Direct challenge of HepG2 with PA (200 μM) increased MD2‐TLR4 complex formation and expression of pro‐inflammatory and pro‐fibrotic genes and L6H21 pre‐treatment prevented these PA‐induced responses. Interestingly, MD2 knockout or L6H21 increased expression of the anti‐inflammatory molecule, PPARγ, in liver tissue and the liver cell line. Our results provide further evidence for the critical role of MD2 in the development of NASH and conclude that MD2 could be a potential therapeutic target for NAFLD/NASH treatment. Moreover, the small molecule MD2 inhibitor, L6H21, was an effective and selective investigative agent for future mechanistic studies of MD2.     

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury

Background

Acute lung injury (ALI) and its most severe form acute respiratory distress syndrome (ARDS) have been the leading cause of morbidity and mortality in intensive care units (ICU). Currently, there is no effective pharmacological treatment for acute lung injury. Curcumin, extracted from turmeric, exhibits broad anti-inflammatory properties through down-regulating inflammatory cytokines. However, the instability of curcumin limits its clinical application.

Methods

A series of new curcumin analogs were synthesized and screened for their inhibitory effects on the production of TNF-α and IL-6 in mouse peritoneal macrophages by ELISA. The evaluation of stability and mechanism of active compounds was determined using UV-assay and Western Blot, respectively. In vivo, SD rats were pretreatment with c26 for seven days and then intratracheally injected with LPS to induce ALI. Pulmonary edema, protein concentration in BALF, injury of lung tissue, inflammatory cytokines in serum and BALF, inflammatory cell infiltration, inflammatory cytokines mRNA expression, and MAPKs phosphorylation were analyzed. We also measured the inflammatory gene expression in human pulmonary epithelial cells.

Results

In the study, we synthesized 30 curcumin analogs. The bioscreeening assay showed that most compounds inhibited LPS-induced production of TNF-α and IL-6. The active compounds, a17, a18, c9 and c26, exhibited their anti-inflammatory activity in a dose-dependent manner and exhibited greater stability than curcumin in vitro. Furthermore, the active compound c26 dose-dependently inhibited ERK phosphorylation. In vivo, LPS significantly increased protein concentration and number of inflammatory cells in BALF, pulmonary edema, pathological changes of lung tissue, inflammatory cytokines in serum and BALF, macrophage infiltration, inflammatory gene expression, and MAPKs phosphorylation . However, pretreatment with c26 attenuated the LPS induced increase through ERK pathway in vivo. Meanwhile, compound c26 reduced the LPS-induced inflammatory gene expression in human pulmonary epithelial cells.

Conclusions

These results suggest that the novel curcumin analog c26 has remarkable protective effects on LPS-induced ALI in rat. These effects may be related to its ability to suppress production of inflammatory cytokines through ERK pathway. Compound c26, with improved chemical stability and bioactivity, may have the potential to be further developed into an anti-inflammatory candidate for the prevention and treatment of ALI.

Electronic supplementary material

The online version of this article (doi:10.1186/s12931-015-0199-1) contains supplementary material, which is available to authorized users.